Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala, Sweden.
Department of Neuroscience, Karolinska Institutet, Biomedicum 8B Solnavägen 9, 171 65, Solna, Sweden.
Pharmacol Rep. 2020 Apr;72(2):332-339. doi: 10.1007/s43440-020-00069-3. Epub 2020 Mar 2.
Antagonistic adenosine A2A receptor (A2AR)-dopamine D2 receptor (D2R) receptor-receptor interactions have previously been demonstrated in A2AR-D2R heteroreceptor complexes in the rat dorsal striatum. They mainly involve a reduction of affinity in the high-affinity component of the D2R agonist binding site upon activation in vivo of the A2AR by an A2AR agonist. Upon cocaine self-administration, this antagonistic A2AR-D2R interaction disappeared in the dorsal striatum.
In the current experiments, it was tested whether such modifications in the antagonistic A2AR-D2R receptor-receptor interactions can develop also after an acute systemic injection of a low cocaine dose (1 mg/kg; sc).
Microdialysis experiments indicated that acute cocaine did not significantly alter the extracellular dopamine levels in the dorsal striatum of the awake Wistar rats. Competition dopamine receptor binding experiments demonstrated that in the acute cocaine group, the A2AR agonist CGS-21680 produced significantly larger increases in the D2R K values (reduction of high-affinity) versus the saline-injected (i.e. control) group. Furthermore, in the dorsal striatum membrane preparation from acute cocaine-injected rats, CGS-21680 also produced significant increases in the D2R K values (reduction of low-affinity) and in the proportion of D2Rs in the high-affinity state (RH). Such significant effects were not observed with CGS-21680 in the control group.
The molecular mechanism involved in the acute cocaine-induced increase in the antagonistic allosteric A2AR-D2R receptor-receptor interactions may be an increased formation of higher-order complexes A2AR-D2R-sigma1R in which cocaine by binding to the sigma1R protomer also allosterically enhances the inhibitory A2AR-D2R interaction in this receptor complex.
先前在大鼠背侧纹状体的 A2AR-D2R 异源受体复合物中已经证实了拮抗型腺苷 A2A 受体 (A2AR)-多巴胺 D2 受体 (D2R) 受体-受体相互作用。它们主要涉及在体内通过 A2AR 激动剂激活 A2AR 后,D2R 激动剂结合位点的高亲和力成分的亲和力降低。在可卡因自我给药后,这种拮抗型 A2AR-D2R 相互作用在背侧纹状体中消失。
在当前的实验中,测试了在急性全身给予低剂量可卡因(1mg/kg;sc)后,这种拮抗型 A2AR-D2R 受体-受体相互作用是否也会发生变化。
微透析实验表明,急性可卡因并未显著改变清醒 Wistar 大鼠背侧纹状体的细胞外多巴胺水平。竞争多巴胺受体结合实验表明,在急性可卡因组中,A2AR 激动剂 CGS-21680 显著增加了 D2R K 值(高亲和力降低),而与生理盐水注射(即对照)组相比。此外,在急性可卡因注射大鼠的背侧纹状体膜制剂中,CGS-21680 还显著增加了 D2R K 值(低亲和力降低)和 D2R 处于高亲和力状态的比例(RH)。在对照组中,CGS-21680 没有观察到这种显著影响。
急性可卡因诱导的拮抗型变构 A2AR-D2R 受体-受体相互作用增加的分子机制可能是更高阶复合物 A2AR-D2R-sigma1R 的形成增加,其中可卡因通过结合 sigma1R 单体也变构增强了该受体复合物中抑制性 A2AR-D2R 相互作用。